Abstract:Mei Li, 1 Jing Xu, 1, 2 Yujue Wang, 1 Xiaoye Du, 1, 2 Teng Zhang, 1, 2 Yu Chen 1– 3 1 Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200427, People's Republic of China; 2 Clinical Research Institute of Integrative Medicine, Shanghai Academy of Traditional Chinese Medicine, Shanghai, 200437, People's Republic of China; 3 Laboratory of Clinical and Molecular Pharmacology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200427, People's Republic of China Correspondence: Yu Chen, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Shanghai, 200437, People's Republic of China, Tel +86 21 5598 1009, Fax +86 21 5598 1009, Email Purpose: Photoreceptors are specialized retinal neurons responsible for phototransduction. Loss of photoreceptors directly leads to irreversible vision impairment. Pharmacological therapies protecting against photoreceptor degeneration are clinically lacking. Oxidative stress and inflammation are common mechanisms playing important roles in the pathogenesis of photoreceptor degeneration. Astragaloside A (AS-A) is a naturally occurring antioxidant and anti-inflammatory agent with neuroprotective activities. However, the photoreceptor protective effects of AS-A remain unknown. The current study thus aims to illustrate the pharmacological potentials of AS-A in protecting against photoreceptor degeneration. Methods: BALB/c and C57/BL6J mice were exposed to bright light and DNA alkylating agent methyl methanesulfonate (MMS) to develop oxidative stress and DNA damage-mediated photoreceptor degeneration, respectively. Microstructural, morphological and functional assessments were performed to directly evaluate the photoreceptor protective effects of AS-A. Ultrastructural and molecular changes in the retina were examined to better understand the pharmacological mechanisms of AS-A in protecting against photoreceptor degeneration. Results: AS-A protected against bright light-induced photoreceptor impairment. Bright light-induced retinal oxidative stress and photoreceptor cell death were attenuated by AS-A treatment. AS-A treatment mitigated bright light-induced DNA damage, activation of poly (ADP-ribose) polymerase (PARP) and nuclear dislocation of high mobility group box 1 (HMGB1) in photoreceptors. AS-A broadly counteracted bright light-altered retinal gene expression profiles. In particular, AS-A decreased the retinal expression of genes involved in necroptosis and inflammatory responses. Bright light-induced microglial activation was also suppressed as a result of AS-A treatment. Furthermore, AS-A attenuated MMS-induced photoreceptor morphological impairment, elevated expression of pro-necroptotic and proinflammatory genes as well as microglial activation in the retina. Conclusion: The work here demonstrates for the first time that AS-A protects against photoreceptor degeneration in part through mitigating oxidative stress and DNA damage-induced necroptosis and inflammatory responses in the retina. Keywords: retinal degeneration, photooxidative stress, photoreceptor protection, programmed cell death, microglial activation Photoreceptors are the first-order retinal neurons that carry out light detection and phototransduction functions, playing an essential role in initiating vision. 1 Photoreceptor degeneration is responsible for irreversible and progressive vision impairment in patients with age-related macular degeneration (AMD) and inherited retinal degeneration such as retinitis pigmentosa. 2,3 A number of therapies have been evaluated in clinical trials and proven to be either ineffective or inconclusive regarding the efficacy to prevent the loss of photoreceptors in dry AMD. Ongoing clinical trials are also available for the treatment of dry AMD. However, proper photoreceptor protective therapies have not been officially approved for clinical usage to prevent or delay the progression of photoreceptor degeneration. 4 Photoreceptor degenerative disorders can be caused by mutations in the functional genes, environmental insults or a combination of both genetic and environmental factors. Regardless of the etiologies, programmed cell death triggered by oxidative stress is a common mechanism underlying the loss of photoreceptors. 5 Moreover, photoreceptor degeneration is often accompanied and further aggravated by excessive inflammatory responses primarily mediated by activated microglial cel -Abstract Truncated-

REG1A protects retinal photoreceptors from blue light damage

Inhibiting the Activation of MAPK (ERK1/2) in Stressed Müller Cells Prevents Photoreceptor Degeneration

All-Trans Retinoic Acid Attenuates Blue Light-Induced Apoptosis of Retinal Photoreceptors by Upregulating MKP-1 Expression

Blue Light Induces RPE Cell Necroptosis, Which Can Be Inhibited by Minocycline

Light-Induced Retinal Ganglion Cell Damage and the Relevant Mechanisms

Suppressing Autophagy Protects Photoreceptor Cells from Light-Induced Injury.

Maintaining KEAP1 levels in retinal pigment epithelial cells preserves their viability during prolonged exposure to artificial blue light

Antiapoptotic Role of the Cellular Repressor of E1A-stimulated Genes (CREG) in Retinal Photoreceptor Cells in a Rat Model of Light-Induced Retinal Injury.

The Role of Oxidative Stress and Autophagy in Blue-Light-Induced Damage to the Retinal Pigment Epithelium in Zebrafish In Vitro and In Vivo

Illumination from Light-Emitting Diodes (leds) Disrupts Pathological Cytokines Expression and Activates Relevant Signal Pathways in Primary Human Retinal Pigment Epithelial Cells.

Long-term blue light exposure induces RGC-5 cell death in vitro: involvement of mitochondria-dependent apoptosis, oxidative stress, and MAPK signaling pathways

Blue light exposure promotes reactive oxygen stress, apoptosis and suppresses viability, migration and wound healing of cornea via inhibiting PI3K/AKT signaling pathway in corneal epithelial cells.

Mitochondrial Fission is Required for Blue Light-Induced Apoptosis and Mitophagy in Retinal Neuronal R28 Cells

Long-term Blue Light Exposure Impairs Mitochondrial Dynamics in the Retina in Light-Induced Retinal Degeneration in Vivo and in Vitro

Protective effects of autophagy against blue light-induced retinal degeneration in aged mice

Light-Induced Lipocalin 2 Facilitates Cellular Apoptosis by Positively Regulating Reactive Oxygen Species/Bim Signaling in Retinal Degeneration

Resveratrol Protects Photoreceptors by Blocking Caspase- and PARP-dependent Cell Death Pathways

Astragaloside A Protects Against Photoreceptor Degeneration in Part Through Suppressing Oxidative Stress and DNA Damage-Induced Necroptosis and Inflammation in the Retina

Inhibition of the MAPK/c-Jun-EGR1 Pathway Decreases Photoreceptor Cell Death in the rd1 Mouse Model for Inherited Retinal Degeneration

Involvement of XBP1s in Blue Light-Induced A2E-Containing Retinal Pigment Epithelium Cell Death

Suppressing endoplasmic reticulum stress-related autophagy attenuates retinal light injury